Abstract
Keywords
Gliptins; Dipeptidyl peptidase-4 (DPP-4) inhibitors; Pioglitazone; Type 2 diabetes mellitus
Bibliographic citation
Programa d'Harmonització Farmacoterapèutica. Alogliptina/pioglitazona per al tractament de la diabetis mellitus tipus 2. Barcelona: Servei Català de la Salut; 2019.
Audience
Professionals
Use this identifier for quote and/or link this document
https://hdl.handle.net/11351/3035.2This item appears in following collections
The following license files are associated with this item: